These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35953331)

  • 1. Debulking different Corona (SARS-CoV-2 delta, omicron, OC43) and Influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and transmission.
    Daniell H; Nair SK; Guan H; Guo Y; Kulchar RJ; Torres MDT; Shahed-Al-Mahmud M; Wakade G; Liu YM; Marques AD; Graham-Wooten J; Zhou W; Wang P; Molugu SK; de Araujo WR; de la Fuente-Nunez C; Ma C; Short WR; Tebas P; Margulies KB; Bushman FD; Mante FK; Ricciardi RP; Collman RG; Wolff MS
    Biomaterials; 2022 Sep; 288():121671. PubMed ID: 35953331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Debulking SARS-CoV-2 in saliva using angiotensin converting enzyme 2 in chewing gum to decrease oral virus transmission and infection.
    Daniell H; Nair SK; Esmaeili N; Wakade G; Shahid N; Ganesan PK; Islam MR; Shepley-McTaggart A; Feng S; Gary EN; Ali AR; Nuth M; Cruz SN; Graham-Wooten J; Streatfield SJ; Montoya-Lopez R; Kaznica P; Mawson M; Green BJ; Ricciardi R; Milone M; Harty RN; Wang P; Weiner DB; Margulies KB; Collman RG
    Mol Ther; 2022 May; 30(5):1966-1978. PubMed ID: 34774754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Carbohydrate-Binding Protein from the Edible Lablab Beans Effectively Blocks the Infections of Influenza Viruses and SARS-CoV-2.
    Liu YM; Shahed-Al-Mahmud M; Chen X; Chen TH; Liao KS; Lo JM; Wu YM; Ho MC; Wu CY; Wong CH; Jan JT; Ma C
    Cell Rep; 2020 Aug; 32(6):108016. PubMed ID: 32755598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H; Peng X; Jiao H; Zhao D; Ouyang J
    Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid and universal detection of SARS-CoV-2 and influenza A virus using a reusable dual-channel optic fiber immunosensor.
    Yang Y; Zhao R; Wang Y; Song D; Jiang B; Guo X; Liu W; Long F; Song H; Hao R
    J Med Virol; 2022 Nov; 94(11):5325-5335. PubMed ID: 35859097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Recombinant VSV-Based Bivalent Vaccine Effectively Protects against Both SARS-CoV-2 and Influenza A Virus Infection.
    Ao Z; Ouyang MJ; Olukitibi TA; Warner B; Vendramelli R; Truong T; Meilleur C; Zhang M; Kung S; Fowke KR; Kobasa D; Yao X
    J Virol; 2022 Sep; 96(18):e0133722. PubMed ID: 36069551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of SARS-CoV-2 viral load in exhaled air by antiseptic chewing gum: a pilot trial.
    Pfab F; Buelow-Johansen B; Alber D; Kriner M; Kornmann O; Stuermer M
    Infection; 2023 Aug; 51(4):881-885. PubMed ID: 36260282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Practice and thinking of acute respiratory infection surveillance for the response of emerging respiratory diseases in Shanghai].
    Chen J; Zheng YX; Kong DC; Wu HY; Yuan ZA; Wu F
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):1994-1998. PubMed ID: 32539259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusion-inhibition peptide broadly inhibits influenza virus and SARS-CoV-2, including Delta and Omicron variants.
    Zhao H; Meng X; Peng Z; Lam H; Zhang C; Zhou X; Chan JF; Kao RYT; To KK; Yuen KY
    Emerg Microbes Infect; 2022 Dec; 11(1):926-937. PubMed ID: 35259078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous monitoring of eight human respiratory viruses including SARS-CoV-2 using liquid chromatography-tandem mass spectrometry.
    Hodgkins C; Buckton LK; Walker GJ; Crossett B; Cordwell SJ; Horvath AR; Rawlinson WD
    Sci Rep; 2022 Aug; 12(1):13392. PubMed ID: 35927299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triazavirin might be the new hope to fight Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Hudecová IMJČGKMPL
    Ceska Slov Farm; 2021; 70(1):18-25. PubMed ID: 34237949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020.
    Panatto D; Orsi A; Pennati BM; Lai PL; Mosca S; Bruzzone B; Caligiuri P; Napoli C; Bertamino E; Orsi GB; Manini I; Loconsole D; Centrone F; Pandolfi E; Ciofi Degli Atti ML; Concato C; Linardos G; Onetti Muda A; Raponi M; Piccioni L; Rizzo C; Chironna M; Icardi G
    PLoS One; 2021; 16(12):e0260947. PubMed ID: 34874956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
    Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
    Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid and sensitive detection of SARS-CoV-2 virus in human saliva samples using glycan based nanozyme: a clinical study.
    Rokni M; Rohani Bastami T; Meshkat Z; Reza Rahimi H; Zibaee S; Meshkat M; Fotouhi F; Serki E; Khoshakhlagh M; Dabirifar Z
    Mikrochim Acta; 2023 Dec; 191(1):36. PubMed ID: 38108890
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Marchesi I; Sala A; Frezza G; Paduano S; Turchi S; Bargellini A; Borella P; Cermelli C
    J Occup Environ Hyg; 2021 Dec; 18(12):541-546. PubMed ID: 34637686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omicron-induced interferon signaling prevents influenza A H1N1 and H5N1 virus infection.
    Bojkova D; Bechtel M; Rothenburger T; Kandler JD; Hayes L; Olmer R; Martin U; Jonigk D; Ciesek S; Wass MN; Michaelis M; Cinatl J
    J Med Virol; 2023 Mar; 95(3):e28686. PubMed ID: 36938992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
    Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
    J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle composite TPNT1 is effective against SARS-CoV-2 and influenza viruses.
    Chang SY; Huang KY; Chao TL; Kao HC; Pang YH; Lu L; Chiu CL; Huang HC; Cheng TR; Fang JM; Yang PC
    Sci Rep; 2021 Apr; 11(1):8692. PubMed ID: 33888738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resurgence of Influenza Circulation in the Russian Federation during the Delta and Omicron COVID-19 Era.
    Sominina A; Danilenko D; Komissarov A; Karpova L; Pisareva M; Fadeev A; Konovalova N; Eropkin M; Stolyarov K; Shtro A; Burtseva E; Lioznov D
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.